Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence
- 26 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gastric Cancer
- Vol. 23 (5), 874-883
- https://doi.org/10.1007/s10120-020-01065-5
Abstract
Background Metabolomics is useful for analyzing the nutrients necessary for cancer progression, as the proliferation is regulated by available nutrients. We studied the metabolomic profile of gastric cancer (GC) tissue to elucidate the associations between metabolism and recurrence. Methods Cancer and adjacent non-cancerous tissues were obtained in a pair-wise manner from 140 patients with GC who underwent gastrectomy. Frozen tissues were homogenized and analyzed by capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS). Metabolites were further assessed based on the presence or absence of recurrence. Results Ninety-three metabolites were quantified. In cancer tissues, the lactate level was significantly higher and the adenylate energy charge was lower than in non-cancerous tissues. The Asp, β-Ala, GDP, and Gly levels were significantly lower in patients with recurrence than in those without. Based on ROC analyses to determine the cut-off values of the four metabolites, patients were categorized into groups at high risk and low risk of peritoneal recurrence. Logistic regression and Cox proportional hazard analyses identified β-Ala as an independent predictor of peritoneal recurrence (hazard ratio [HR] 5.21 [95% confidence interval 1.07–35.89], p = 0.029) and an independent prognostic factor for the overall survival (HR 3.44 [95% CI 1.65–7.14], p < 0.001). Conclusions The metabolomic profiles of cancer tissues differed from those of non-cancerous tissues. In addition, four metabolites were significantly associated with recurrence in GC. β-Ala was both a significant predictor of peritoneal recurrence and a prognostic factor.Keywords
This publication has 28 references indexed in Scilit:
- Metabolomic profiling of oesophago-gastric cancer: A systematic reviewEuropean Journal of Cancer, 2013
- Gastric Cancer: Current Status of Diagnosis and TreatmentCancers, 2013
- Characterization of Ectonucleotidases in Human Medulloblastoma Cell Lines: ecto-5′NT/CD73 in Metastasis as Potential Prognostic FactorPLOS ONE, 2012
- Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS productionCancer Letters, 2012
- Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidityOncology Reports, 2011
- Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemiaMolecular BioSystems, 2011
- Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometryAnalytical and Bioanalytical Chemistry, 2009
- Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesMetabolomics, 2009
- Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass SpectrometryCancer Research, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009